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Sterile leukocyturia affects urine neutrophil  
gelatinase-associated lipocalin concentration in type 2 
diabetic patients 
Agnieszka Gala-Błądzińska1, Agnieszka Żyłka1, Paulina Dumnicka2, Beata Kuśnierz-Cabala3, 
Magdalena Barbara Kaziuk4, Marek Kuźniewski4
A b s t r a c t
Introduction: Increased urine neutrophil gelatinase-associated lipocalin 
(uNGAL) concentrations are associated with the early phase of kidney dam-
age. Urine NGAL may increase due to production by neutrophils present 
in urine, particularly in patients with urinary tract infections. The aim of 
the study was to assess the relationship between sterile leukocyturia and 
uNGAL concentrations in patients with type 2 diabetes (DMt2) at early stages 
of diabetic kidney disease. 
Material and methods: The study included 115 DMt2 patients aged 60.0 
±15.5 years, with albuminuria < 300 mg/g creatinine and estimated glo-
merular filtration rate ≥ 60 ml/min/1.73 m² prospectively recruited at the 
nephrology ambulatory clinic in 2014–2015. The exclusion criteria were 
urinary tract infections (excluded by urine culture) and other diseases in-
fluencing uNGAL, including inflammatory and other kidney diseases. Urine 
concentrations of NGAL, albumin and creatinine were measured in the first 
morning samples, and the urine albumin to creatinine ratio (UACR) and 
uNGAL to creatinine ratio (UNCR) were calculated. Leukocyturia was detect-
ed microscopically. 
Results: Sterile leukocyturia was present in 15% (95% confidence interval: 
9–23%) of patients. Patients with leukocyturia had higher uNGAL and UNCR 
than patients without leukocyturia. ln(UNCR) correlated with ln(UACR) in 
the whole group (R = 0.59; p < 0.001) and in patients without leukocyturia 
(R = 0.56; p < 0.001). In multiple regression, age, ln(UACR), ln(HbA1c) and leu-
kocyturia were independent positive predictors of ln(UNCR). Among patients 
with leukocyturia, the associations of UNCR with UACR, age and HbA1c were 
non-significant. 
Conclusions: In patients with DMt2, the presence of sterile leukocyturia co-
exists with increased uNGAL and UNCR. Leukocyturia interferes with the 
relationship between UNCR and UACR or HbA1c.
Key words: diabetic nephropathy, neutrophil gelatinase-associated 
lipocalin, tubular injury biomarkers.
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Introduction
Despite the progress in diagnosis and treat-
ment of diabetic kidney disease (DKD), DKD re-
mains the most frequent cause of chronic kidney 
disease (CKD) including CKD stage 5, or renal 
failure [1]. According to a  report of the United 
States Renal Data System published in 2014, 
patients with DKD constitute nearly 45% of pa-
tients undergoing renal replacement therapy [1]. 
Diabetic kidney disease is frequently attributed 
to glomerular structural changes (enlargement of 
the mesangial space, thickening of the basement 
membrane), as well as damage and loss of podo-
cytes, associated with nodular glomerulosclerosis 
(Kimmelstiel-Wilson nodular disease) [2]. Howev-
er, data accumulating from the 1990s suggest that 
not only changes in glomeruli, but also changes in 
renal tubules and in the interstitial tissue, play an 
important role in the development of DKD, espe-
cially in type 2 diabetes (DMt2) [3]. 
Neutrophil gelatinase-associated lipocalin (NGAL) 
is a  25  kDa protein, initially found in activated 
neutrophils, where it is covalently bound to human 
neutrophil gelatinase. A NGAL is a  secretory pro-
tein belonging to the lipocalin family. Physiologi-
cally, it is expressed at low levels in the kidneys, 
trachea, lungs, stomach and colon [4]; mean urine 
NGAL concentrations in healthy individuals were 
reported to be about 20 ng/ml [5]. In the kidney, 
NGAL is filtered through the glomeruli and then al-
most completely absorbed by the proximal tubules 
in the process of megalin-dependent endocyto-
sis. The concentrations of NGAL in urine (uNGAL) 
may thus increase due to impaired reabsorption 
in proximal tubules. Nevertheless, the main frac-
tion of uNGAL comes from the distal tubule cells 
that synthesize the protein in response to various 
insulting factors [4, 6]. Highly increased uNGAL 
concentrations (> 200–300 ng/ml) are observed 
in patients with acute kidney injury [7]; however, 
the protein is also considered a marker of tubular 
dysfunction in CKD [8]. It was observed that the 
concentrations of both NGAL and other metallo-
proteinases in serum are higher in CKD patients, 
particularly in hemodialysis patients [9, 10].
Several studies have shown that uNGAL is 
higher among patients with leukocyturia caused 
by infections of the urinary tract [11, 12]. How-
ever, we have found no studies investigating the 
impact of sterile leukocyturia on the values of uN-
GAL and urine NGAL to creatinine ratio (UNCR) in 
DMt2 patients. 
The aim of this study was to investigate the as-
sociation of sterile leukocyturia with uNGAL con-
centrations and UNCR among DMt2 patients at 
early stages of DKD. Also, we studied the associa-
tions of uNGAL and UNCR with clinically important 
patients’ characteristics, including sex, age, body 
mass index (BMI), diabetes duration, glycohemo-
globin (HbA1c), estimated glomerular filtration 
rate (eGFR), albuminuria, serum cholesterol and 
triglyceride concentrations.
Material and methods
Patients
The observational study involved DMt2 pa-
tients, aged 18 and above, with eGFR above 60 ml/ 
min/1.73 m², urine albumin to creatinine ratio 
(UACR) < 300 mg/g, and without urinary tract in-
fections, prospectively recruited between Novem-
ber 2014 and August 2015 at the ambulatory clinic 
of the Nephrology Department of a clinical hospital 
(St Queen Jadwiga District Hospital No. 2 in Rze-
szow, Poland). Diabetes mellitus type 2 was diag-
nosed in accordance with the recommendations 
of the American Diabetes Association [13]. Urinary 
tract infections were excluded by the interview and 
urine examination, including urine culture. Other 
exclusion criteria were: treatment with potential-
ly nephrotoxic agents, kidney diseases other than 
DKD, cancer, documented allergy or autoimmune 
disease, anemia, unstable hypertension, pregnan-
cy and acute disease or inflammation. 
The control group included adult non-diabetic 
patients, with eGFR > 60 ml/min/1.73 m², without 
proteinuria, leukocyturia or urinary tract infection, 
who attended the control visits at the Ambulatory 
Clinic of the Nephrology Department due to stable 
hypertension or benign simple kidney cyst. The 
exclusion criteria were the same as for the study 
group. The control group was meant solely to pro-
vide an insight into uNGAL concentration and UNCR 
values among non-diabetic subjects with age, sex 
and co-morbidities similar to those observed in the 
studied diabetic patients. The reference ranges for 
uNGAL are provided by the manufacturer of the 
test, and the aim of including the control group was 
only to verify this information; therefore the control 
group was not planned to be large.
The study was conducted according to the Dec-
laration of Helsinki and its protocol was approved 
by the Bioethical Committee of the Polish Cham-
ber of Physicians (approval number 40/2013/B). 
All the participants gave written informed consent 
for the study.
Laboratory tests
The laboratory tests were conducted at the 
Clinical Department of Laboratory Diagnostics of 
St. Queen Jadwiga District Hospital No. 2 in Rze-
szow, Poland. All tests were performed on the day 
of sample collection. 
The first morning samples of urine were collect-
ed using the midstream collection method into 
sterile containers and were used for urine culture, 
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general urine examination, and measurements 
of NGAL, albumin, and creatinine concentrations. 
Blood samples for laboratory tests were collected 
after an overnight fast. The HbA
1c was measured 
in K
2EDTA-anticoagulated whole blood. The con-
centrations of glucose, C-reactive protein, creati-
nine, triglycerides (TG), total cholesterol, low-den-
sity lipoprotein (LDL) cholesterol and high-density 
lipoprotein (HDL) cholesterol were measured in 
serum. White blood cell count was performed with 
an ADVIA 2120i Siemens 5-diff hematological an-
alyzer (Siemens Healthcare Diagnostic, Germany).
The general urine examination was carried out 
using the Labumat-Urised 2 analyzer and micro-
scopic examination of urine sediment. Urinary 
tract infection was excluded by urine culture in pa-
tients with leukocyturia, i.e. 10 or more leukocytes 
per high power field in urine sediment examina-
tion. The concentration of uNGAL was measured 
using the chemiluminescent microparticle immu-
noassay (ARCHITECT, Abbott Diagnostics, Abbott 
Park, USA). Urine albumin concentrations were 
measured with the immunoturbidimetric assay, 
and urine creatinine with the enzymatic method 
with creatinine and creatinine using an Olympus 
AU680 Immunochemistry analyzer. The UACR was 
calculated as urine albumin [mg/l]/urine creat-
inine [g/l] and UNCR as uNGAL [µg/l]/urine cre-
atinine [g/l]. The HbA
1c was measured with the 
immunochromatographic method. The GFR values 
were estimated using the 2009 CKD-EPI equation, 
which was recommended as the standard way for 
determining eGFR [14].
Statistical analysis
Data for categories are shown as number of 
patients and percentage of the appropriate group, 
with 95% confidence interval (95% CI) for the pro-
portion (calculated using the Wilson procedure 
with a correction for continuity). Mean ± standard 
deviation or median (25–75 percentile) is shown 
for continuous variables with or without normal 
distribution (as tested with the Shapiro-Wilk test). 
Groups were compared using the c2 test, one-way 
analysis of variance (ANOVA) or Kruskal-Wallis 
ANOVA, with Bonferroni’s post-hoc tests (the dif-
ferences in post-hoc tests were considered signifi-
cant at p ≤ 0.016). The Mann-Whitney test or t-test 
was used for comparisons between 2 groups. 
Simple correlations were studied using Pearson’s 
coefficient, after log-transformation (normal log-
arithm) of right-skewed variables. Linear multiple 
regression was calculated using predictors that 
were significantly or nearly significantly (p ≤ 0.1) 
correlated with the dependent variable in simple 
regression. Results were considered significant at 
p ≤ 0.05. Statistica 10.0 (StatSoft, Tulsa, USA) soft-
ware was used for computations.
Results 
Among 115 diabetic patients studied, 17 (15%; 
95% CI: 9–23%) had sterile leukocyturia. Diabetic 
patients with leukocyturia had significantly high-
er urine NGAL and albumin (both non-standard-
ized concentrations and the values normalized to 
urine creatinine) than diabetic patients without 
leukocyturia and non-diabetic subjects (Table I). 
Serum creatinine concentrations and eGFR values 
did not differ between the groups. The percentage 
of women among patients with leukocyturia was 
significantly higher than among subjects without 
leukocyturia (Table I).
Urine NGAL concentrations were significant-
ly correlated with urine albumin concentrations 
(log-transformed variables) in the whole group of 
diabetic patients (R = 0.59; p < 0.001) and in pa-
tients without leukocyturia (R = 0.57; p < 0.001); 
the same associations were found between UNCR 
and UACR (Figure 1). However, these correlations 
were non-significant in diabetic patients with leu-
kocyturia (Figure 1). 
Diabetic women had higher uNGAL and UNCR 
than diabetic men: 18.3 (8.7–44.8) vs. 14.2 (6.1–
24.8) ng/ml; p = 0.035 and 28.1 (9.0–65.7) vs. 11.3 
(3.3–18.0) µg/g; p < 0.001, respectively. Among 
patients without leukocyturia, only UNCR was 
significantly associated with sex (Figure 2). In the 
control group, there were no significant differenc-
es between sexes regarding uNGAL, which was 
non-significantly higher in men (20.1 (7.4–38.4) 
vs. 8.3 (5.0–20.1) (p = 0.1)), and UNCR, which was 
non-significantly higher in women: 12.5 (6.0–28.3) 
vs. 7.7 (5.5–13.7) µg/g (p = 0.3). There were no 
sex-related differences regarding urine albumin or 
UACR, both in diabetic patients and non-diabetic 
controls.
In diabetic patients without leukocyturia, 
ln(UNCR) was significantly correlated with age 
(R = 0.22; p = 0.028); there was no such correla-
tion for ln(uNGAL). Urine NGAL and UNCR were 
not correlated with the duration of diabetes, and 
there were no differences between patients with 
newly diagnosed diabetes compared to the rest of 
the group, irrespectively of leukocyturia. However, 
both ln(uNGAL) and ln(UNCR) were significantly 
associated with ln(HbA1c) in the whole group of di-
abetic patients (R = 0.34; p = 0.003 and R = 0.30; 
p = 0.008, respectively) and in subjects without 
leukocyturia (R = 0.46; p < 0.001 and R = 0.44; 
p < 0.001). The correlations were not significant in 
patients with leukocyturia (R = –0.02; p = 0.9 and 
R = –0.12; p = 0.7, respectively).
There were no correlations between uNGAL or 
UNCR and BMI. Also, uNGAL and UNCR did not cor-
relate with eGFR in our group of diabetic patients, 
irrespectively of leukocyturia (p-values ≥ 0.2). We 
noted no correlations of uNGAL and UNCR with 
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serum lipid concentrations, except for a  weak 
negative correlation between HDL-cholesterol 
and ln(uNGAL) in patients without leukocyturia 
(R = –0.25; p = 0.021), and a  similar correla-
tion with ln(UNCR) in patients with leukocyturia 
(R = –0.51; p = 0.050). There were no differenc-
es in uNGAL or UNCR between patients with and 
without hypertension. Also, treatment with statin 
or RAA blockade was not associated with signifi-
cant differences in uNGAL concentrations or UNCR 
values.
In multiple regression (Table II), ln(urine al-
bumin), ln(HbA1c) and leukocyturia significant-
ly predicted ln(uNGAL), whereas age, ln(UACR), 
ln(HbA1c) and leukocyturia were independent pre-
dictors of ln(UNCR).
Discussion
In the studied group of DMt2 patients with 
stage 1 and 2 CKD, the presence of leukocyturia 
was an independent predictor for uNGAL and 
UNCR concentrations. Urine NGAL and UNCR val-
ues were significantly higher in patients with leu-
kocyturia than in patients without leukocyturia. In 
fact, uNGAL and UNCR in DMt2 patients without 
leukocyturia did not differ significantly from the 
control group, which may reflect the impact of co-
Table I. Clinical characteristics of the groups and laboratory data 
Parameter Non-diabetic 
patients without 
leukocyturia
(N = 21)
Diabetic patients P-value*
Without  
leukocyturia
(N = 98)
With  
leukocyturia  
(N = 17)
Female sex, n (%/95% CI) 11 (52/30–74)a 45 (46/36–56)b 16 (94/69–100)a,b 0.001
Age [years] 56.6 ±14.9 62.1 ±12.4 59.2 ±18.5 NS
BMI [kg/m2] 27.8 ±5.3c 31.8 ±5.8c 32.0 ±5.5 0.017
Diabetes duration [years] – 6 (2–10) 10 (5–15) NS$
Newly diagnosed diabetes, n (%/95% CI) – 19 (19/12–29) 2 (12/2–38) NS$
HbA1c (%) – 6.5 (5.9–8.6) 6.7 (6.2–8.2) NS
$
HbA1c [mmol/mol] – 48 (41–70) 50 (44–66) NS
$
Total cholesterol [mmol/l] 5.13 (4.47–6.97) 4.76 (3.90–5.77) 5.42 (4.33–6.22) NS
HDL cholesterol [mmol/l] 3.97 (2.96–5.13)c 2.84 (1.99–3.75)c 3.05 (2.40–4.01) 0.007
LDL cholesterol [mmol/l] 1.27 (1.18–1.49) 1.19 (0.96–1.42) 1.24 (1.01–1.47) NS
Triglycerides [mmol/l] 1.51 (0.85–1.99) 1.63 (1.26–2.13) 2.51 (1.23–3.17) NS
Serum creatinine [µmol/l] 71.6 (70.7–79.6)a 68.1 (60.1–78.7) 61.9 (53.0–68.1)a 0.008
eGFR (CKD-EPI) [ml/min/1.73 m2] 84 (77–99) 93 (79–100) 88 (81–98) NS
Urine creatinine [g/l] 1.39 (0.71–2.24) 1.04 (0.69–1.62) 0.86 (0.60–1.44) NS
Urine NGAL [µg/l] 10.5 (6.0–24.6)a 13.7 (6.1–22.0)b 72.2 (45.6–133.0)a,b < 0.001
UNCR [µg/g] 11.9 (5.9–15.9)a 11.4 (5.4–26.8)b 88.4 (65.7–198.8)a,b < 0.001
Urine albumin [mg/l] 5.7 (3.0–12.0)a 6.8 (3.1–13.2)b 25.1 (11.4–36.8)a,b 0.006
UACR [mg/g] 4.7 (3.6–8.7)a 5.8 (3.1–15.1)b 16.1 (7.8–50.1)a,b 0.002
Hypertension, n (%/95% CI) 14 (67/43–85) 78 (80/70–87) 13 (76/50–92) NS
Ischemic heart disease, n (%/95% CI) 2 (10/2–32) 22 (22/15–32) 1 (6/0–31) NS
Heart failure, n (%/95% CI) 2 (10/2–32) 8 (8/4–16) 1 (6/0–31) NS
RAA blockade (ACEI or AT1-blockers),  
n (%/95% CI)
11 (52/30–74) 67 (68/58–77) 14 (82/56–95) NS
Statin, n (%/95% CI) 10 (48/26–70) 51 (52/42–62) 7 (41/19–67) NS
*P-value for the overall difference between 3 groups; superscript numbers denote statistically significant post-hoc tests: ap ≤ 0.016 for the 
difference between non-diabetic patients and diabetic patients with leukocyturia; bp ≤ 0.016 for the difference between diabetic patients 
with and without leukocyturia; cp ≤ 0.016 for the difference between non-diabetic patients and diabetic patients without leukocyturia; 
$p-value for the difference between diabetic patients with and without leukocyturia.
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morbidities, e.g. hypertension. Leukocytes may be 
the source of uNGAL in patients with leukocyturia. 
The leukocytes present in urine may derive from 
all parts of the urinary tract; however, the routine 
laboratory tests do not allow for identification of 
the source of leukocyturia. Determining the cause 
of leukocyturia requires a detailed interview, thor-
ough physical examination including gynecologi-
cal and urological consultation, as well as imaging 
or endoscopic examination of the urinary tract. In 
our study, patients with leukocyturia and positive 
urine cultures were excluded [15].
However, sterile leukocyturia in studied pa-
tients may also be associated with the injury of 
kidney tubular epithelial cells and increased ex-
pression of NGAL in tubular cells. Ding et al. [8] 
found that the increase of NGAL is an early bio-
marker of tubular epithelial injury in IgA nephrop-
athy. Also, several authors support the tubulo-cen-
tric theory of DKD in a group of patients with DMt2. 
Clinical observations suggest that hyperglycemia, 
atherogenic dyslipidemia, obesity or hyperten-
sion, all commonly observed in DMt2, may lead 
to the development of an inflammatory state in 
the tubular-epithelial tissue, increased production 
of extracellular matrix, and the epithelial mes-
enchymal transition of renal tubular cells [8, 16]. 
Due to the inflammatory state, the tubular-epithe-
lial tissue becomes infiltrated by leukocytes and 
monocytes, which, being transformed into tissue 
macrophages, induce reparatory changes and 
fibrosis. Because of this process, leading to irre-
versible kidney failure, DKD can be considered an 
inflammatory disease [17, 18]. The recommended 
therapy in these patients includes, inter alia, lip-
id-lowering and antihypertensive therapy [14, 19], 
anti-diabetic drugs [20], and lifestyle changes to 
reduce overweight and obesity [21].
The present study has shown that in DMt2 pa-
tients, albuminuria correlated independently with 
higher values of uNGAL and UNCR. The increased 
excretion of albumin in the urine remains a recog-
Figure 1. Relationship between UACR and UNCR in 
diabetic patients without leukocyturia (black dots, 
solid line) and with leukocyturia (open squares, 
dotted line). Correlation coefficients and p-values 
are shown for the whole group of diabetic patients, 
subjects without leukocyturia and subjects with 
leukocyturia
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Figure 2. Gender-related differences in UNCR 
among diabetic patients without leukocyturia
Data are shown as median, 25th–75th percentile (boxes), 
and range (whiskers); points represent row data.
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Table II. Multiple regression to predict uNGAL concentrations and UNCR in DMT2 patients
Independent variable ln(uNGAL) ln(UNCR)
Beta ± SE P-value Beta ± SE P-value
Age – – 0.25 ±0.09 0.006
Female sex 0.07 ±0.09 0.4 0.14 ±0.08 0.078
ln(HbA1c) 0.18 ±0.09 0.039 0.31 ±0.09 0.001
HDL-C –0.15 ±0.08 0.068 – –
ln(urine albumin) 0.39 ±0.09 < 0.001 – –
ln(UACR) – – 0.28 ±0.09 0.003
Leukocyturia 0.45 ±0.09 < 0.001 0.46 ±0.08 < 0.001
Whole model R2 = 0.56 < 0.001 R2 = 0.59 < 0.001
HDL-C – HDL cholesterol.
p = 0.020
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nized risk factor for CKD [13, 22]. This observation 
is consistent with other studies [23, 24]. The pres-
ent study indicates, however, that the presence of 
leukocyturia interferes with this positive correla-
tion between uNGAL and albuminuria (it is not 
significant among patients with leukocyturia). It 
may be a consequence of the relatively low num-
ber of patients with leukocyturia in this study. 
However, if the increased number of leukocytes 
in urine is associated with tubular cells’ injury, it 
may be assumed that this group of patients has 
an increased predisposition for tubulopathy rather 
than glomerulopathy in the course of DMt2. The 
group with DMt2 and sterile leukocyturia may 
presumably develop the clinical phenotype of the 
disease without progression to severely increased 
albuminuria [25]. Consistently, in the present 
study, uNGAL and UNCR were not correlated with 
DMt2 duration. Thus, in some patients, uNGAL 
and UNCR seem more promising and earlier mark-
ers of DMt2-associated kidney disease than UACR. 
However, this issue requires further prospective 
studies recruiting much higher numbers of DMt2 
patients.
The present study did not show a  significant 
correlation between eGFR and uNGAL or UNCR, 
in contrast to the negative correlation described 
in several publications [23, 26, 27]. However, the 
study groups differed from those of Bolignano 
et al. [23], and the method used for eGFR calcula-
tion differed from the one used by Yang et al. [27]. 
This may in part explain the discrepancy.
In the studied DMt2 patients, sterile leukocy-
turia coinciding with high uNGAL and UNCR was 
observed predominantly in women. Even among 
DMt2 patients without leukocyturia, the highest 
UNCR values were generally seen in females than 
in males. These observations may reflect high-
er susceptibility to tubular kidney injury in the 
course of DMt2 among women with CKD stages 
G1-G2/A1-A2. This corresponds to the results of 
the UKPDS study, indicating that even in the ab-
sence of albuminuria women with DMt2 are more 
prone to the development of progressive kidney 
injury in the course of DMt2 [28]. Also, in the study 
of Cullen et al. [11], 95th percentiles for uNGAL and 
UNCR were higher in women.
Additionally, a  weak but independent correla-
tion of uNGAL and UNCR with HbA
1c was observed 
in patients with DMt2. There was, however, no 
such correlation in a  subgroup of patients with 
leukocyturia. In the study by Nielsen et al. [24], 
including 177 patients with eGFR and albumin-
uria (a sample comparable to those studied here), 
a similar positive correlation of HbA
1c and UNCR 
was observed. Nevertheless, these authors pro-
vide no information on the prevalence of leukocy-
turia in their patients. Finally, in the present study, 
there was a positive correlation between age and 
UNCR. The presence of leukocyturia rendered this 
correlation statistically insignificant, which may 
result from the relatively low number of patients 
with leukocyturia. Another hypothesis is that in 
some DMt2 patients, renal tubules are prone to 
early damage independently of age. 
In summary, it appears that the presence of 
leukocyturia does not eliminate the possibility to 
use uNGAL and UNCR for the assessment of kid-
ney tubular injury. However, leukocyturia should 
be taken into account when interpreting the re-
sults. In patients with acute kidney injury and co-
existing leukocyturia, Cullen et al. [11] suggested 
a correction of the cut-off value for uNGAL. In turn, 
Decavele et al. [12] proposed a formula to correct 
uNGAL concentrations depending on numbers of 
urinary leukocytes in patients with urinary tract 
infections. The issue of uNGAL corrections in pa-
tients with DKD remains open.
In conclusion, the presence of sterile leuko-
cyturia was observed in 15% of DMt2 patients, 
mainly women. The presence of leukocyturia in 
this group requires a thorough differential diag-
nostics, taking into account the fact that leuko-
cyturia may indicate tubular epithelial kidney 
injury. One of the possible diagnostic tests used 
to assess the dysfunction of renal tubules in the 
course of DMt2 is the measurement of uNGAL in 
a single urine sample and calculation of UNCR. In 
patients with leukocyturia, it has to be remem-
bered that the presence of leukocytes in urine 
leads to increased uNGAL and UNCR. Moreover, 
in such patients, the correlations between UNCR 
and albuminuria, HbA1c or age are diminished. In 
our opinion, there is a need for further prospec-
tive studies to validate the clinical usefulness 
of uNGAL and UNCR for the detection of kidney 
disease in DMt2, recruiting higher numbers of 
patients, and including those with sterile leuko-
cyturia.
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